Galera Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.52
|
-0.60
|
-0.08
|
-15.38%
|
|
2022-06-30
|
-0.53
|
-0.54
|
-0.01
|
-1.89%
|
|
2022-03-31
|
-0.57
|
-0.58
|
-0.01
|
-1.75%
|
|
2021-12-31
|
-0.75
|
-0.64
|
0.11
|
14.67%
|
|
2021-09-30
|
-0.76
|
-0.86
|
-0.10
|
-13.16%
|
|
2021-06-30
|
-0.83
|
-0.88
|
-0.05
|
-6.02%
|
|
2021-03-31
|
-0.83
|
-0.75
|
0.08
|
9.64%
|
|
2020-12-31
|
-0.71
|
-0.80
|
-0.09
|
-12.68%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.72
|
|
2021-12-31
|
-3.13
|
|
2020-12-31
|
-2.98
|
|
2019-12-31
|
-2.97
|